垂体腺瘤的基因治疗
Gene therapy for pituitary adenomas
出处
《中华神经医学杂志》
CAS
CSCD
2005年第8期855-857,共3页
Chinese Journal of Neuromedicine
关键词
垂体肿瘤
基因疗法
Pituitary neoplasms
Gene therapy
参考文献15
-
1Castro MG. Gene therapy strategies for the treatment of pituitary tumours[J]. J Mol Endocrinol, 1999, 22(1): 9-18.
-
2Castro MG, Goya RG, Sosa YE, et al. Expression of transgenes in normal and neoplastic anterior pituitary cells using recombinant adenoviruses: long term expression, cell cycle dependency, and effects on hormone secretion [J]. Endocrinology, 1997, 138 (5):2184-2194.
-
3Windeatt S, Southgate TD, Dewey RA, et al. Adenovirus-mediated herpes simplex virus type-1 thymidine kinase gene therapy suppresses oestrogen-induced pituitary prolactinomas [J]. J Clin Endocrinol Metab, 2000, 85(3): 1296-1305.
-
4Bolognani F, Goya RG. Gene therapy in the neuroendocrine system:its implementation in experimental models using viral vectors [J].Neuroendocrinology, 2001, 73(2): 75-83.
-
5Frost S J, Simpson DJ, Clayton RN, et al. Transfection of an inducible p16/CDKN2A construct mediates reversible growth inhibition and G1 arrest in the AtT20 pituitary tumor cell line[J]. Mol Endocrinol,1999, 13(11): 1801-1810.
-
6Freese A, During MJ, Davidson BL, et al. Transfection of human lactotroph adenoma cells with an adenovirus vector expressing tyrosine hydroxylase decreases prolactin release[J]. J Clin Endocrinol Metab, 1996, 81 (6): 2401-2404.
-
7Castro MG, Windeatt S, Smith-Arica J, et al. Cell-type specific expression in the pituitary: physiology and gene therapy[J]. Biochem Soc Trans, 1999, 27(6): 858-863.
-
8Goya RG, Rowe J, Sosa YE, et al. Use of recombinant herpes simplex virus type vectors for gene transfer into tumors and normal anterior pituitary cells [J]. Mol Cell Endocrinol, 1998, 139(1-2):199-207.
-
9Lee E J, Anderson LM, Thimmapaya B, et al. Targeted expression of toxic genes directed by pituitary hormone promoters: a potential strategy for adenovirus-mediated gene therapy of pituitary tumors[J].J Clin Endocrinol Metab, 1999, 84(2): 786-794.
-
10Lee E J, Martinson F, Kotlar T, et al. Adenovirus-mediated targeted expression of toxic genes to adrenocorticotropin-producing pituitary tumors using the proopiomelanocortin promoter [J]. J Clin Endocrinol Metab, 2001, 86(7): 3400-3409.
二级参考文献22
-
1Molitch ME. Medical treatment of prolactinomas.Endocrinol Metab Clin North Am, 1999, 28(1):143-169.
-
2Brown ER, Coker GT, O' Malley KL. Organization and evolution of the rat tyrosine hydroxylase gene. Biochemistry,1987, 26(16):5208-5212.
-
3Freese A, During M J, Davidson BL, et al. Transfection of human lactotroph adenoma cells with an adenovirus vector expressing tyrosine hydroxylase decreases prolactin release.J Clin Endocrinol Metab, 1996, 81(6):2401-2404.
-
4He TC, Zhou SB, Costar LTD, et al. A simplified system for generating recombinant adenovirus. Proc Nail Acad Sci USA, 1998, 95(5):2509-2514.
-
5Colao A, Annunziato L, Lombardi G. Treatment of prolactinomas. Ann Med, 1998, 30(5):452-459.
-
6Tyrrell JB, Lambom KR, Hannegan LT, et al. Transsphenoidal microsurgical therapy of prolactinomas: initial outcomes and long-term results. Neurosurgey, 1999, 44(2):254-263.
-
7During M J, Naegele JR, O' Malley KL, et al. Long-term behavioral recovery in Parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science, 1994, 266(25):1399-1403.
-
8Moffat M, Harmon S, Haycock J, et al. L-dopa and dopamine-producing gene cassettes for gene therapy approaches to Parkinson's disease. Exp Neurol, 1997, 144(1):69-73.
-
9Windeatt S, Southgate TD, Dewey RA, et al. Adenovirusmediated herpes simplex virus type-1 thymidine kinase gene therapy suppresses oestrogen-induced pituitary prolactinomas.J Clin Endocrinol Metab, 2000, 85(3):1296-1305.
-
10Neill JD, Musgrove LC, Duck LW, et al. High efficiency method for gene transfer in normal pituitary gonadotropes:adenoviral-mediated expression of G protein-coupled receptor kinase 2 suppresses luteinizing hormone secretion. Endocrinology, 1999, 140(6):2562-2569.
共引文献6
-
1苏志鹏,吴哲褒,于春江.泌乳素腺瘤耐溴隐亭治疗的研究进展[J].中华神经外科杂志,2006,22(6):386-387. 被引量:8
-
2连文峰,林向阳,张素英,王春仙,杨永安,于洋,宫香宇,陈艳军,张敏.人端粒酶逆转录酶启动子调控腺病毒介导胸苷激酶基因治疗人膀胱癌的动物实验研究[J].中国肿瘤临床,2007,34(18):1058-1061. 被引量:5
-
3刘金龙,刘训良,钱清,杜青,郭仕英,李朝军,苗毅.辐射诱导性自杀基因在胰腺癌细胞中的表达[J].中华医学杂志,2008,88(28):1952-1955. 被引量:2
-
4刘洁,蒋小龙,陈云祥,苏志鹏,李强,吴近森,吴哲褒.腺病毒介导D2S基因联合溴隐亭治疗对GH3细胞生长的抑制作用[J].中华神经外科杂志,2012,28(3):295-298. 被引量:2
-
5刘丽娜,冯玉桃.CP化疗方案对卵巢癌患者血清IL-2及CA125含量的影响[J].肿瘤药学,2012,2(6):439-442. 被引量:2
-
6徐恩斌,张忠兵,谢渭芬,宁守斌,林勇,蔡洪培.乙酰胆碱酯酶基因重组腺病毒的构建及其对猫食管平滑肌细胞的影响[J].世界华人消化杂志,2004,12(1):117-120. 被引量:2
-
1冯敏,赵洪洋.垂体腺瘤的基因治疗[J].中国临床神经外科杂志,2007,12(11):694-697.
-
2陈曦.多发性内分泌肿瘤Ⅰ型相关的胰腺内分泌肿瘤[J].中国实用外科杂志,2010,30(9):759-762. 被引量:1
-
3许蓉蓉,周家华.组织蛋白酶D在恶性肿瘤中的研究进展[J].国际外科学杂志,2012,39(3):192-196. 被引量:2
-
4司亚萌,赵怡芳.婴幼儿血管瘤发生机制的研究进展[J].中国口腔颌面外科杂志,2006,4(4):311-314. 被引量:3
-
5毛允义,王金根,孟栋良.肾上腺嗜铬细胞瘤的诊治[J].江西医学院学报,2005,45(4):67-67.
-
6于顺江,陈力,王京.垂体瘤中Ikaros的异常表达及其临床意义的研究[J].中华实验外科杂志,2009,26(12):1747-1748.
-
7张太平,王天笑.胰岛素瘤诊治策略[J].外科理论与实践,2011,16(5):436-439. 被引量:4
-
8许元腾,杨劲松,张榕,林功标.喉鳞癌微环境中DCs分布与VEGF的表达相关性研究[J].中国耳鼻咽喉颅底外科杂志,2008,14(6):419-423.
-
9张骏,邓宏宇,巫刚,李双庆.多发性骨髓瘤148例临床分析[J].临床荟萃,2005,20(8):452-454. 被引量:24
-
10苗毅,郭峰,奚春华,徐泽宽,钱祝银,戴存才,刘训良,蒋奎荣,吴峻立.胰腺内分泌肿瘤的外科治疗[J].肝胆外科杂志,2007,15(3):168-171. 被引量:7